Cite

    Yalamanchali, A. et al. (2023). Comparison of real‐world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials. Head & neck. 45 (4), pp. 862-871. [Online].